Mpox vaccine maker Bavarian Nordic seeks ‘critical’ approval for teens

Mpox vaccine maker Bavarian Nordic seeks ‘critical’ approval for teens

Jackyenjoyphotography | Moment | Getty Images LONDON — Danish biotech company Bavarian Nordic said Friday that it had submitted data to the Europe Union’s drug regulator to extend the use of its mpox vaccine for teenagers. CEO Paul Chaplin told CNBC that the expanded approval for 12 to 17 year-olds would be crucial in tackling … Read more

What’s next for Biden’s Medicare drug price negotiations

What’s next for Biden’s Medicare drug price negotiations

U.S. President Joe Biden and Vice President Kamala Harris walk out together, at an event on Medicare drug price negotiations, in Prince George’s County, Maryland, U.S., August 15, 2024.  Ken Cedeno | Reuters The Biden administration on Thursday reached a milestone in Democrats’ decades-long quest to use Medicare to drive down prescription drug costs, releasing … Read more

Health stocks jump as WHO declares global health emergency

Health stocks jump as WHO declares global health emergency

Colorized transmission electron micrograph of monkeypox virus particles (red) found within an infected cell (blue), cultured in the laboratory. Bsip | Universal Images Group | Getty Images LONDON — Shares of Danish vaccine maker Bavarian Nordic jumped as much as 17% Thursday amid a wider rally for associated healthcare stocks after the World Health Organization … Read more

Medicare releases prices for first 10 drugs subject to negotiations

Medicare releases prices for first 10 drugs subject to negotiations

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images The Biden administration on Thursday will release prices for the first 10 prescription drugs that were subject to landmark negotiations between drugmakers and … Read more

Ro launches GLP-1 insurance coverage checker

Ro launches GLP-1 insurance coverage checker

Zoom In IconArrows pointing outwards The direct-to-consumer health-care startup Ro launched a new free tool Tuesday to help patients determine whether their insurance covers a buzzy class of weight loss and diabetes drugs called GLP-1s.  Most insurance plans cover GLP-1s when they are used to treat diabetes, so those patients can usually avoid the roughly … Read more

Eli Lilly’s earnings rally is not done yet — plus, why TJX has stayed resilient in the volatility

Eli Lilly’s earnings rally is not done yet — plus, why TJX has stayed resilient in the volatility

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Mixed Markets: The S & P 500 is trying to finish the week out on a higher note after fluctuating between gains and losses for a … Read more

Eli Lilly (LLY) earnings Q2 2024

Eli Lilly (LLY) earnings Q2 2024

The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, on Sept. 17, 2020. Mike Blake | Reuters Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion as sales of its blockbuster diabetes drug Mounjaro and … Read more

CVS Health (CVS) earnings Q2 2024

CVS Health (CVS) earnings Q2 2024

The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store in Las Vegas, Nevada on Feb. 7, 2024. Patrick T. Fallon | AFP | Getty Images CVS Health on Wednesday reported second-quarter earnings that topped expectations, but slashed its full-year profit outlook, citing higher medical costs that have been squeezing … Read more

Eli Lilly Zepbound, Mounjaro available after shortages, FDA says

Eli Lilly Zepbound, Mounjaro available after shortages, FDA says

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, Dec. 11, 2023. Brendan McDermid | Reuters All doses of Eli Lilly’s highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the U.S., according to an update on the Food and Drug Administration’s drug … Read more

Biogen (BIIB) earnings Q2 2024

Biogen (BIIB) earnings Q2 2024

A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Thursday reported second-quarter earnings and revenue that topped estimates and hiked its full-year guidance, as the company’s cost cuts showed progress and sales of its breakthrough Alzheimer’s drug, Leqembi, and … Read more